AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: Berry, DA
Citation: Da. Berry, Role of population-based studies in assessing genetic cancer risk, J NAT CANC, 93(16), 2001, pp. 1188-1189

Authors: Berry, DA Verdolini, K Montequin, DW Hess, MM Chan, RW Titze, IR
Citation: Da. Berry et al., A quantitative output-cost ratio in voice production, J SPEECH L, 44(1), 2001, pp. 29-37

Authors: Hayes, DF Yamauchi, H Broadwater, G Cirrincione, CT Rodrigue, SP Berry, DA Younger, J Panasci, LL Millard, F Duggan, DB Norton, L Henderson, IC
Citation: Df. Hayes et al., Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and leukemia group B study 8662, CLIN CANC R, 7(9), 2001, pp. 2703-2711

Authors: Zhang, W Laborde, PM Coombes, KR Berry, DA Hamilton, SR
Citation: W. Zhang et al., Cancer genomics: Promises and complexities, CLIN CANC R, 7(8), 2001, pp. 2159-2167

Authors: Harris, LN Liotcheva, V Broadwater, G Ramirez, MJ Maimonis, P Anderson, S Everett, T Harpole, D Moore, MB Berry, DA Rizzeri, D Vredenburgh, JJ Bentley, RC
Citation: Ln. Harris et al., Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy, J CL ONCOL, 19(6), 2001, pp. 1698-1706

Authors: Lewis, RJ Berry, DA Cryer, H Fost, N Krome, R Washington, GR Houghton, J Blue, JW Bechhofer, R Cook, T Fisher, M
Citation: Rj. Lewis et al., Monitoring a clinical trial conducted under the food and drug administration regulations allowing a waiver of prospective informed consent: The diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial, ANN EMERG M, 38(4), 2001, pp. 397-404

Authors: Berry, DA Clark, MJO Montequin, DW Titze, IR
Citation: Da. Berry et al., Characterization of the medial surface of the vocal folds, ANN OTOL RH, 110(5), 2001, pp. 470-477

Authors: Berry, DA Montequin, DW Tayama, N
Citation: Da. Berry et al., High-speed digital imaging of the medial surface of the vocal folds, J ACOUST SO, 110(5), 2001, pp. 2539-2547

Authors: Guidi, AJ Berry, DA Broadwater, G Perloff, M Norton, L Barcos, MP Hayes, DF
Citation: Aj. Guidi et al., Association of angiogenesis in lymph node metastases with outcome of breast cancer, J NAT CANC, 92(6), 2000, pp. 486-492

Authors: Iversen, ES Parmigiani, G Berry, DA Schildkraut, JM
Citation: Es. Iversen et al., Genetic susceptibility and survival: Application to breast cancer, J AM STAT A, 95(449), 2000, pp. 28-42

Authors: Kupfer, DJ Baltimore, RS Berry, DA Breslau, N Ellinwood, EH Ferre, J Ferriero, DM Fuchs, LS Guze, SB Hamburg, BA McGlothlin, J Turner, SM Vonnegut, M Abikoff, H Anderson, S Arnold, LE Barkley, RA Biederman, J Bird, HR Breggin, PR Carey, WB Chemers, B Conners, CK Cooper, JR Danielson, L Feussner, G Forness, SR Greenhill, LL Hinshaw, SP Hoagwood, K Jensen, PS Johnston, C Kalivas, PW Kelleher, KJ Klein, RG Lahey, BB Lambert, NM Loney, J Pelham, WE Rowland, AS Swanson, J Tannock, R Wilens, TE Wolraich, ML
Citation: Dj. Kupfer et al., National Institutes of Health Consensus Development Conference Statement: Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD), J AM A CHIL, 39(2), 2000, pp. 182-193

Authors: Berry, DA Muss, HB Thor, AD Dressler, L Liu, ET Broadwater, G Budman, DR Henderson, IC Barcos, M Hayes, D Norton, L
Citation: Da. Berry et al., HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer, J CL ONCOL, 18(20), 2000, pp. 3471-3479

Authors: Berry, DA Balcar, VJ Barden, JA Keogh, A dos Remedios, CG
Citation: Da. Berry et al., Determination of P2X(1)alpha-sarcoglycan (adhalin) expression levels in failing human dilated cardiomyopathic left ventricles, ELECTROPHOR, 21(17), 2000, pp. 3857-3862

Authors: Brooks, PJ Wise, DS Berry, DA Kosmoski, JV Smerdon, MJ Somers, RL Mackie, H Spoonde, AY Ackerman, EJ Coleman, K Tarone, RE Robbins, JH
Citation: Pj. Brooks et al., The oxidative DNA lesion 8,5 '-(S)-cyclo-2 '-deoxyadenosine is repaired bythe nucleotide excision repair pathway and blocks gene expression in mammalian cells, J BIOL CHEM, 275(29), 2000, pp. 22355-22362

Authors: Alipour, F Berry, DA Titze, IR
Citation: F. Alipour et al., A finite-element model of vocal-fold vibration, J ACOUST SO, 108(6), 2000, pp. 3003-3012

Authors: Samant, KD Berry, DA Ng, KM
Citation: Kd. Samant et al., Representation of high-dimensional, molecular solid-liquid phase diagrams, AICHE J, 46(12), 2000, pp. 2435-2455

Authors: Berry, DA Thor, AD
Citation: Da. Berry et Ad. Thor, erbB-2, p53, and efficacy of adjuvant therapy in lymph node positive breast cancer - Response, J NAT CANC, 91(8), 1999, pp. 728-729

Authors: Berry, DA
Citation: Da. Berry, Benefits and risks of screening mammography for women in their forties: a statistical appraisal - Response, J NAT CANC, 91(4), 1999, pp. 383-384

Authors: Berry, DA Budman, DR
Citation: Da. Berry et Dr. Budman, Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer - Response, J NAT CANC, 91(3), 1999, pp. 286-287

Authors: Berry, DA Budman, DR
Citation: Da. Berry et Dr. Budman, Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer - Response, J NAT CANC, 91(16), 1999, pp. 1425-1425

Authors: Berry, DA Moon, JB Kuehn, DP
Citation: Da. Berry et al., A finite element model of the soft palate, CLEF PAL-CR, 36(3), 1999, pp. 217-223

Authors: Costanza, ME Weiss, RB Henderson, IC Norton, L Berry, DA Cirrincione, C Winer, E Wood, WC Frei, E McIntyre, OR Schilsky, RL
Citation: Me. Costanza et al., Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: Report of a randomized study - Cancer and leukemia group B 8642, J CL ONCOL, 17(5), 1999, pp. 1397-1406

Authors: Parmigiani, G Berry, DA Winer, EP Tebaldi, C Iglehart, JD Prosnitz, LR
Citation: G. Parmigiani et al., Is axillary lymph node dissection indicated for early-stage breast cancer?A decision analysis, J CL ONCOL, 17(5), 1999, pp. 1465-1473

Authors: Bluman, LG Rimer, BK Berry, DA Borstelmann, N Iglehart, JD Regan, K Schildkraut, J Winer, EP
Citation: Lg. Bluman et al., Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2, J CL ONCOL, 17(3), 1999, pp. 1040-1046

Authors: Abrams, J Aisner, J Cirrincione, C Berry, DA Muss, HB Cooper, MR Henderson, IC Panasci, L Kirshner, J Ellerton, J Norton, L
Citation: J. Abrams et al., Dose-response trial of megestrol acetate in advanced breast cancer: Cancerand leukemia group B phase III study 8741, J CL ONCOL, 17(1), 1999, pp. 64-73
Risultati: 1-25 | 26-27